Pharmaceuticals, Biotechnology and Life Sciences
ViiV Healthcare, a HIV specialist company (majority) owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, on Wednesday…
Symcel has secured €3.572 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against…
Oxford Pharmascience has received scientific advice from the MPA (Swedish regulatory authority) about the development programme for future marketing authorisation…
The European Commission (EC) has approved Novartis’s Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic…
Pneumonia represents a significant health risk in the very young and very old, and mortality rates remain high among the…
US Food and Drug Administration (FDA) has approved a new indication for AstraZeneca’s Faslodex(fulvestrant), expanding the indication to include use with…
Cardinal Health will sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding for $1.2 billion.
Hikma Pharmaceuticals has acquired six products from Boehringer Ingelheim GmbH (Boehringer Ingelheim).
Novartis announced it would present data across its breast cancer portfolio and pipeline in a broad range of patient populations,…
Beximco Pharmaceuticals last week started the export of Sotalol Hydrochloride, a generic version of the cardiovascular drug Betapace, to the US.